Physician

Adam Chad Lessne, M.D.

According to 2025 Medicare claims, Adam Lessne, M.D. (NPI: 1740504778) practices gastroenterology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is GASTRO HEALTH, LLC (NPI: 1457026932; TIN: 203400983) and primary practice location at 33021-3416.

Lessne's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 300 traditional Medicare patients, billed 5,982 HCPCS/CPT codes, and received $159,841 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,390 prescription claims across 426 beneficiaries totaling $1,018,645 in drug costs, led by Sucraid (Sacrosidase). 2020 DME data shows 22 claims. Open Payments data shows 133 records totaling $3,575. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $54,429 and ending at $159,841. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $597,917 to $1,018,645. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	249	638	$54,429
2017	535	1,568	$134,327
2018	475	1,286	$117,195
2019	411	3,170	$127,074
2020	325	6,297	$209,484
2021	349	8,196	$201,322
2022	282	5,030	$141,083
2023	308	1,698	$91,680
2024	300	5,982	$159,841

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	84	320	$597,917
2016	69	229	$337,549
2017	73	199	$15,234
2018	196	504	$102,842
2019	295	815	$131,590
2020	290	894	$262,297
2021	347	1,037	$462,150
2022	341	1,110	$441,265
2023	421	1,241	$891,598
2024	426	1,390	$1,018,645

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	22	$2,639
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	48	48	$203
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	64	64	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	113	154	$93
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	55	55	$58
45380	Biopsy of large bowel using a flexible endoscope	42	42	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sucraid	Sacrosidase	28	840	$286,471
Creon	Lipase/Protease/Amylase	67	2,233	$286,094
Linzess	Linaclotide	108	6,626	$113,766
Clenpiq	Sod Picosulf/Mag Ox/Citric Ac	88	189	$14,950
Dexlansoprazole Dr	Dexlansoprazole	13	930	$5,709

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	133	$3,575	Phathom Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Chad Lessne, M.D.?

Tedicare shows public-source Medicare data for Adam Chad Lessne, M.D. (NPI 1740504778), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Chad Lessne, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Chad Lessne, M.D.?

Adam Chad Lessne, M.D. is linked to GASTRO HEALTH, LLC (billing NPI 1457026932) in the available physician profile data.

Does Adam Chad Lessne, M.D. have Open Payments data?

Adam Chad Lessne, M.D. has 133 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.